Tekla Life Sciences Investors (HQL) Insider Trading
- $7,085,451.16
- $4,076,654.28
- May 20, 2025
- Saba Capital Management, L.P.
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 25, 2018 | Director | 1,300 | $21.04 | Buy | $27,352.00 |
Insiders are both buying and selling Tekla Life Sciences Investors stock.
The insider traders at Tekla Life Sciences Investors are: Saba Capital Management, L.P., Daniel R Omstead, Kathleen Goetz, Thomas M Kent, Bill Maher, Todd Reit, Daniel R. Omstead, and Rose Dimartino
The most active insider trader at Tekla Life Sciences Investors is Saba Capital Management, L.P. with 37 trades.
Saba Capital Management, L.P. has sold the most Tekla Life Sciences Investors stock with a total value of $4,221,789.77.
Saba Capital Management, L.P. has bought the most Tekla Life Sciences Investors stock with a total value of $6,157,720.77.
The most recent insider trade for Tekla Life Sciences Investors was on May 20, 2025.
The single biggest insider buy for Tekla Life Sciences Investors was from Saba Capital Management, L.P. with a total value of $1,563,952.00 on April 26, 2024.
The single biggest insider sell for Tekla Life Sciences Investors was from Saba Capital Management, L.P. with a total value of $611,677.34 on March 31, 2025.